Since 2002, Dr. Anil Sood has worked at M.D. Anderson Cancer Center in Houston, Texas, where he serves as the director of the Blanton-Davis Ovarian Cancer Research Program. Moreover, Dr. Anil Sood is a member of various organizations, including the American Association for Cancer Research (AACR).
In January 2018, AACR named Chi Van Dang, MD, PhD, the new editor-in-chief of its peer-reviewed medical journal, Cancer Research—one of the most influential oncological research publications in the world. The journal regularly publishes opinion pieces, reviews, and original studies on different areas of cancer research. Moreover, its peer-review process is rigorous: Only studies that are broadly relevant to the field, groundbreaking, and timely get accepted.
Dr. Dang, a trailblazer in biomedical cancer research, presently holds the title of scientific director at the Ludwig Institute for Cancer Research and is a member of faculty at The Wistar Institute. In his comments regarding the development, he stated that he looked forward to working with the new editorial board to promote significant scientific findings that encouraged team science and original and creative research paradigms.